BusinessPetLife Pharmaceuticals Announces the Addition of Dr. Simon Wood PhD as the Company’s new Scientific Officer with plans to expand its Current Portfolio of Veterinarian Drugs and NutraceuticalsBy Nasdaq OMXOct 19, 2016, 7:15 PM UTC
BusinessPetLife Pharmaceuticals is Pleased to Announce the Completion of the New Company WebsiteBy Nasdaq OMXOct 17, 2016, 12:01 PM UTC
BusinessPetLife Pharmaceuticals Expands Cell Line Study with InnoVision in Preparation for FDA/CVM Registration SubmissionBy Nasdaq OMXOct 13, 2016, 12:02 PM UTC
BusinessPetLife Pharmaceuticals is Pleased to Showcase its New “Vitalzul™ Information Video” along with a Corporate UpdateBy Nasdaq OMXOct 10, 2016, 12:00 PM UTC
BusinessPetLife Pharmaceuticals Explores Product Expansion with Strategic Partner(s); Successfully Presents at Two Financial Conferences in SeptemberBy Nasdaq OMXSep 28, 2016, 2:30 PM UTC
BusinessPetLife Pharmaceuticals Continues Execution of its Vitalzul TM Business Plan with start of Proof of Concept studies; Provides UpdatesBy Nasdaq OMXSep 14, 2016, 1:10 PM UTC
BusinessPetLife Pharmaceuticals Hires InnoVision Therapeutics in Preparation of Vitalzul™ FDA SubmissionBy Nasdaq OMXAug 25, 2016, 12:43 PM UTC
